Cetuximab or panituximab differentially impact miRNA expression and potential signaling pathway in cancer colon HCT116 or HT29 cells in vitro

ABSTRACT: Aiming to understaned resistance to monocolonal antibodies (Cetuximab, Ctx or Panituximab, Pani) in colon cancer cells, miRNA were studies in both HT29 cells(B-RAF mutated, moderattely-sensitive to Ctx) and HCT116 (K-RAS mutated, highly resistant to Ctx)

ORGANISM(S): Homo sapiens

PROVIDER: GSE316424 | GEO | 2026/05/04

REPOSITORIES: GEO